Combined evaluation of prolactin-induced peptide (PIP) and extracellular signal-regulated kinase (ERK) as new sperm biomarkers of FSH treatment efficacy in normogonadotropic idiopathic infertile men.

ERK1/2 FSH FSH treatment Idiopathic infertility PIP Spermatozoa

Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
22 Jul 2023
Historique:
received: 14 05 2023
accepted: 17 07 2023
medline: 22 7 2023
pubmed: 22 7 2023
entrez: 22 7 2023
Statut: aheadofprint

Résumé

Nearly, 40% of the causes of male infertility remain idiopathic. The only suggested treatment in idiopathic oligo- and/or asthenozoospermia in normogonadotropic patients is the FSH. In the current clinical practice, efficacy is exclusively assessable through semen analysis after 3 months of treatment. No molecular markers of treatment efficacy are appliable in clinical practice. The aim of the present work is to evaluate the combination of extracellular signal regulated kinase (ERK) 1 and 2 and prolactin inducible peptide (PIP) as potential markers of idiopathic infertility and FSH treatment efficacy. Western blot and confocal microscopy were performed to analyze the modulation of PIP and ERK1/2 in idiopathic infertile patients (IIP) sperm cells. Taking advantage of mass spectrometry analysis, we identified these proteins unequivocally in sperm cells.  We demonstrated a significant decrease of both PIP protein and of ERK1/2 levels in spermatozoa obtained from IIP in comparison to healthy fertile patients (HFP). Conversely, we reported a significant increase of these markers comparing infertile patients before and after 3 months of FSH treatment. Importantly, this correlated with an increase in total number of sperm and sperm motility after FSH treatment. Finally, we identified of PIP and ERK2 proteins in sperm samples by proteomic analysis. The combined evaluation of ERK1/2 and PIP proteins might represent a useful molecular marker to tailor FSH treatment in the management of male normogonadotropic idiopathic infertility.

Identifiants

pubmed: 37480475
doi: 10.1007/s40618-023-02161-w
pii: 10.1007/s40618-023-02161-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Références

Vander Borght M, Wyns C (2018) Fertility and infertility: definition and epidemiology. Clin Biochem 62:2–10. https://doi.org/10.1016/J.CLINBIOCHEM.2018.03.012
doi: 10.1016/J.CLINBIOCHEM.2018.03.012 pubmed: 29555319
Garolla A, Pizzol D, Carosso AR et al (2021) Practical clinical and diagnostic pathway for the investigation of the infertile couple. Front Endocrinol (Lausanne) 11:1032. https://doi.org/10.3389/FENDO.2020.591837/BIBTEX
doi: 10.3389/FENDO.2020.591837/BIBTEX
Cousineau TM, Domar AD (2007) Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol 21:293–308. https://doi.org/10.1016/J.BPOBGYN.2006.12.003
doi: 10.1016/J.BPOBGYN.2006.12.003 pubmed: 17241818
Bourrion B, Panjo H, Bithorel PL et al (2022) The economic burden of infertility treatment and distribution of expenditures overtime in France: a self-controlled pre-post study. BMC Health Serv Res 22:1–10. https://doi.org/10.1186/S12913-022-07725-9/FIGURES/3
doi: 10.1186/S12913-022-07725-9/FIGURES/3
Kumar N, Singh A (2015) Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci 8:191. https://doi.org/10.4103/0974-1208.170370
doi: 10.4103/0974-1208.170370 pubmed: 26752853 pmcid: 4691969
Ventimiglia E, Pozzi E, Capogrosso P et al (2021) Extensive assessment of underlying etiological factors in primary infertile men reduces the proportion of men with idiopathic infertility. Front Endocrinol (Lausanne) 12:801125. https://doi.org/10.3389/fendo.2021.801125
doi: 10.3389/fendo.2021.801125 pubmed: 35002977
Ferlin A, Calogero AE, Krausz C et al (2022) Management of male factor infertility: position statement from the Italian Society of andrology and sexual medicine (SIAMS): endorsing organization: Italian society of embryology, reproduction, and research (SIERR). J Endocrinol Invest 45:1085–1113. https://doi.org/10.1007/S40618-022-01741-6
doi: 10.1007/S40618-022-01741-6 pubmed: 35075609
Foresta C, Bettella A, Ferlin A et al (1998) Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 69:636–642. https://doi.org/10.1016/S0015-0282(98)00008-9
doi: 10.1016/S0015-0282(98)00008-9 pubmed: 9548151
Foresta C, Bettella A, Merico M et al (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77:238–244. https://doi.org/10.1016/S0015-0282(01)02966-1
doi: 10.1016/S0015-0282(01)02966-1 pubmed: 11821078
Arnaldi G, Balercia G, Barbatelli G, Mantero F (2000) Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia 32:155–161. https://doi.org/10.1046/J.1439-0272.2000.00358.X
doi: 10.1046/J.1439-0272.2000.00358.X pubmed: 10863970
Ben-Rafael Z, Farhi J, Feldberg D et al (2000) Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 73:24–30. https://doi.org/10.1016/S0015-0282(99)00461-6
doi: 10.1016/S0015-0282(99)00461-6 pubmed: 10632407
Muratori M, Baldi E (2018) Effects of FSH on sperm DNA fragmentation: review of clinical studies and possible mechanisms of action. Front Endocrinol (Lausanne) 9:734. https://doi.org/10.3389/FENDO.2018.00734
doi: 10.3389/FENDO.2018.00734 pubmed: 30619081
Santi D, Crépieux P, Reiter E et al (2020) Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles. J Clin Med. https://doi.org/10.3390/JCM9041014
doi: 10.3390/JCM9041014 pubmed: 32260182 pmcid: 7230878
Simoni M, Brigante G, Rochira V et al (2020) Prospects for FSH Treatment of male infertility. J Clin Endocrinol Metab. https://doi.org/10.1210/CLINEM/DGAA243
doi: 10.1210/CLINEM/DGAA243 pubmed: 32374828
Ponce MDR, Foresta C, Rago R et al (2020) Use of biosimilar follicle-stimulating hormone in asthenozoospermic infertile patients: a multicentric study. J Clin Med 9:1478. https://doi.org/10.3390/JCM9051478
doi: 10.3390/JCM9051478
Barbonetti A, Calogero AE, Balercia G et al (2018) The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS). J Endocrinol Invest. https://doi.org/10.1007/s40618-018-0843-y
doi: 10.1007/s40618-018-0843-y pubmed: 29729005
Santi D, Granata ARM, Simoni M (2015) FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 4:R46. https://doi.org/10.1530/EC-15-0050
doi: 10.1530/EC-15-0050 pubmed: 26113521 pmcid: 4512277
Cannarella R, La Vignera S, Condorelli RA et al (2020) FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies. Asian J Androl 22:309–316. https://doi.org/10.4103/AJA.AJA_42_19
doi: 10.4103/AJA.AJA_42_19 pubmed: 31274479
Attia AM, Abou-Setta AM, Al-Inany HG (2013) Gonadotrophins for idiopathic male factor subfertility. Cochrane database Syst Rev. https://doi.org/10.1002/14651858.CD005071.PUB4
doi: 10.1002/14651858.CD005071.PUB4 pubmed: 23970458
Simoni M, Santi D, Negri L et al (2016) Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p. N680S: a pharmacogenetic study. Hum Reprod 31:1960–1969. https://doi.org/10.1093/HUMREP/DEW167
doi: 10.1093/HUMREP/DEW167 pubmed: 27329968
Grande G, Vincenzoni F, Mancini F et al (2019) Quantitative analysis of the seminal plasma proteome in secondary hypogonadism. J Clin Med 8:2128. https://doi.org/10.3390/JCM8122128
doi: 10.3390/JCM8122128 pubmed: 31816910 pmcid: 6947469
Hassan MI, Waheed A, Yadav S et al (2009) Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications. Cell Mol Life Sci 66:447–459. https://doi.org/10.1007/S00018-008-8463-X
doi: 10.1007/S00018-008-8463-X pubmed: 18854942
Martínez-Heredia J, de Mateo S, Vidal-Taboada JM et al (2008) Identification of proteomic differences in asthenozoospermic sperm samples. Hum Reprod 23:783–791. https://doi.org/10.1093/HUMREP/DEN024
doi: 10.1093/HUMREP/DEN024 pubmed: 18281682
Arthur JSC, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13:679–692. https://doi.org/10.1038/nri3495
doi: 10.1038/nri3495 pubmed: 23954936
Nan X, Tamgüney TM, Collisson EA et al (2015) Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proc Natl Acad Sci USA 112:7996–8001. https://doi.org/10.1073/PNAS.1509123112
doi: 10.1073/PNAS.1509123112 pubmed: 26080442 pmcid: 4491781
Bianchetti G, Taralli S, Vaccaro M et al (2022) Automated detection and classification of tumor histotypes on dynamic PET imaging data through machine-learning driven voxel classification. Comput Biol Med. https://doi.org/10.1016/J.COMPBIOMED.2022.105423
doi: 10.1016/J.COMPBIOMED.2022.105423 pubmed: 35367782
Bianchetti G, Di Giacinto F, De Spirito M, Maulucci G (2020) Machine-learning assisted confocal imaging of intracellular sites of triglycerides and cholesteryl esters formation and storage. Anal Chim Acta 1121:57–66. https://doi.org/10.1016/J.ACA.2020.04.076
doi: 10.1016/J.ACA.2020.04.076 pubmed: 32493590
Berg S, Kutra D, Kroeger T et al (2019) ilastik: interactive machine learning for (bio)image analysis. Nat Methods 16:1226–1232. https://doi.org/10.1038/S41592-019-0582-9
doi: 10.1038/S41592-019-0582-9 pubmed: 31570887
Barbonetti A, Calogero AE, Balercia G et al (2018) The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of andrology and sexual medicine (SIAMS). J Endocrinol Invest 41:1107–1122. https://doi.org/10.1007/S40618-018-0843-Y
doi: 10.1007/S40618-018-0843-Y pubmed: 29392544
Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773. https://doi.org/10.1210/EDRV.18.6.0320
doi: 10.1210/EDRV.18.6.0320 pubmed: 9408742
Gloaguen P, Crépieux P, Heitzler D et al (2011) Mapping the follicle-stimulating hormone-induced signaling networks. Front Endocrinol (Lausanne). https://doi.org/10.3389/FENDO.2011.00045
doi: 10.3389/FENDO.2011.00045 pubmed: 22666216
Hunzicker-Dunn M, Maizels ET (2006) FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 18:1351–1359. https://doi.org/10.1016/J.CELLSIG.2006.02.011
doi: 10.1016/J.CELLSIG.2006.02.011 pubmed: 16616457 pmcid: 1564187
Conti AC, Cryan JF, Dalvi A et al (2002) cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262–3268. https://doi.org/10.1523/JNEUROSCI.22-08-03262.2002
doi: 10.1523/JNEUROSCI.22-08-03262.2002 pubmed: 11943827 pmcid: 6757540
Casarini L, Crépieux P (2019) Molecular mechanisms of action of FSH. Front Endocrinol (Lausanne) 10:305. https://doi.org/10.3389/FENDO.2019.00305/BIBTEX
doi: 10.3389/FENDO.2019.00305/BIBTEX pubmed: 31139153
Garrido N, Martínez-Conejero JA, Jauregui J et al (2009) Microarray analysis in sperm from fertile and infertile men without basic sperm analysis abnormalities reveals a significantly different transcriptome. Fertil Steril 91:1307–1310. https://doi.org/10.1016/J.FERTNSTERT.2008.01.078
doi: 10.1016/J.FERTNSTERT.2008.01.078 pubmed: 18367176
Bansal SK, Gupta N, Sankhwar SN, Rajender S (2015) Differential genes expression between fertile and infertile spermatozoa revealed by transcriptome analysis. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0127007
doi: 10.1371/JOURNAL.PONE.0127007 pubmed: 26484662 pmcid: 4613143
Cui L, Fang L, Shi B et al (2018) Spermatozoa expression of piR-31704, piR-39888, and piR-40349 and their correlation to sperm concentration and fertilization rate after ICSI. Reprod Sci 25:733–739. https://doi.org/10.1177/1933719117725822/METRICS
doi: 10.1177/1933719117725822/METRICS pubmed: 28826361
Agarwal A, Parekh N, Selvam MKP et al (2019) Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World J Mens Health 37:296. https://doi.org/10.5534/WJMH.190055
doi: 10.5534/WJMH.190055 pubmed: 31081299 pmcid: 6704307
Bruno C, Basile U, Vergani E et al (2022) Inflammation and oxidative stress in seminal plasma: search for biomarkers in diagnostic approach to male infertility. J Pers Med. https://doi.org/10.3390/JPM12060857
doi: 10.3390/JPM12060857 pubmed: 36013293 pmcid: 9409900
Mongioì LM, Condorelli RA, Alamo A et al (2020) Follicle-stimulating hormone treatment and male idiopathic infertility: effects on sperm parameters and oxidative stress indices according to FSHR c. 2039 A/G and c. -29 G/A genotypes. J Clin Med. https://doi.org/10.3390/JCM9061690
doi: 10.3390/JCM9061690 pubmed: 32759752 pmcid: 7463896
Milardi D, Grande G, Vincenzoni F et al (2014) Novel biomarkers of androgen deficiency from seminal plasma profiling using high-resolution mass spectrometry. J Clin Endocrinol Metab 99:2813–2820. https://doi.org/10.1210/JC.2013-4148
doi: 10.1210/JC.2013-4148 pubmed: 24796927
Buscà R, Pouysségur J, Lenormand P (2016) ERK1 and ERK2 map kinases: Specific roles or functional redundancy? Front Cell Dev Biol 4:53. https://doi.org/10.3389/FCELL.2016.00053/BIBTEX
doi: 10.3389/FCELL.2016.00053/BIBTEX pubmed: 27376062 pmcid: 4897767
Almog T, Lazar S, Reiss N et al (2008) Identification of extracellular signal-regulated kinase 1/2 and p38 MAPK as regulators of human sperm motility and acrosome reaction and as predictors of poor spermatozoan quality. J Biol Chem 283:14479–14489. https://doi.org/10.1074/JBC.M710492200
doi: 10.1074/JBC.M710492200 pubmed: 18372245
Almog T, Naor Z (2008) Mitogen activated protein kinases (MAPKs) as regulators of spermatogenesis and spermatozoa functions. Mol Cell Endocrinol 282:39–44. https://doi.org/10.1016/J.MCE.2007.11.011
doi: 10.1016/J.MCE.2007.11.011 pubmed: 18177996
Almog T, Naor Z (2010) The role of mitogen activated protein kinase (MAPK) in sperm functions. Mol Cell Endocrinol 314:239–243. https://doi.org/10.1016/J.MCE.2009.05.009
doi: 10.1016/J.MCE.2009.05.009 pubmed: 19467295
Li MWM, Mruk DD, Cheng CY (2009) Mitogen-activated protein kinases in male reproductive function. Trends Mol Med 15:159–168. https://doi.org/10.1016/J.MOLMED.2009.02.002
doi: 10.1016/J.MOLMED.2009.02.002 pubmed: 19303360 pmcid: 2804913
Dahia CL, Rao AJ (2006) Demonstration of follicle-stimulating hormone receptor in cauda epididymis of rat. Biol Reprod 75:98–106. https://doi.org/10.1095/BIOLREPROD.105.047704
doi: 10.1095/BIOLREPROD.105.047704 pubmed: 16598027
Świder-Al-Amawi M, Kolasa A, Sikorski A et al (2010) The immunoexpression of FSH-R in the ductuli efferentes and the epididymis of men and rat: effect of FSH on the morphology and steroidogenic activity of rat epididymal epithelial cells in vitro. J Biomed Biotechnol. https://doi.org/10.1155/2010/506762
doi: 10.1155/2010/506762 pubmed: 20467586 pmcid: 2868980
Sullivan R (2016) Epididymosomes: role of extracellular microvesicles in sperm maturation. Front Biosci (Schol Ed) 8:106–114. https://doi.org/10.2741/S450
doi: 10.2741/S450 pubmed: 26709900
Sullivan R, Mieusset R (2016) The human epididymis: its function in sperm maturation. Hum Reprod Update 22:574–587. https://doi.org/10.1093/HUMUPD/DMW015
doi: 10.1093/HUMUPD/DMW015 pubmed: 27307387
da Juliano SC, de Ávila ACFCM, Garrett HL et al (2018) Cell-secreted vesicles containing microRNAs as regulators of gamete maturation. J Endocrinol 236:R15–R27. https://doi.org/10.1530/JOE-17-0200
doi: 10.1530/JOE-17-0200
Recchia K, Jorge AS, de Pessôa FLV et al (2021) Actions and roles of FSH in germinative cells. Int J Mol Sci 22:10110. https://doi.org/10.3390/IJMS221810110
doi: 10.3390/IJMS221810110 pubmed: 34576272 pmcid: 8470522
Baccetti B, Collodel G, Costantino-Ceccarini E et al (1998) Localization of human follicle-stimulating hormone in the testis. FASEB J 12:1045–1054. https://doi.org/10.1096/FASEBJ.12.11.1045
doi: 10.1096/FASEBJ.12.11.1045 pubmed: 9707177
Panza S, Giordano F, De Rose D et al (2020) FSH-R human early male genital tract, testicular tumors and sperm: its involvement in testicular disorders. Life 10:1–19. https://doi.org/10.3390/LIFE10120336
doi: 10.3390/LIFE10120336

Auteurs

F Mancini (F)

International Scientific Institute Paul VI, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. mancini.chicca@gmail.com.

F Di Nicuolo (F)

International Scientific Institute Paul VI, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

E Teveroni (E)

International Scientific Institute Paul VI, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

E Vergani (E)

Division of Endocrinology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

G Bianchetti (G)

Department of Neuroscience, Section of Biophysics, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

C Bruno (C)

Division of Endocrinology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

G Grande (G)

Unit of Andrology and Reproductive Medicine, University Hospital Padua, Padua, Italy.

F Iavarone (F)

Department of Laboratory and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

G Maulucci (G)

Department of Neuroscience, Section of Biophysics, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

M De Spirito (M)

Department of Neuroscience, Section of Biophysics, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

A Urbani (A)

Department of Laboratory and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

A Pontecorvi (A)

International Scientific Institute Paul VI, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Division of Endocrinology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

D Milardi (D)

International Scientific Institute Paul VI, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Division of Endocrinology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Classifications MeSH